Skip to content
Biodatica
Start free

The New York Proton Center

New York, New York

OncologyPhase II
Compare Sign in to watch

What changed

Study registered, no phase assigned: Testing the Addition of Activity Monitoring With a Wearable Electronic Device to Improve Patient Care During Treatment for Lung Cancer

2mo agoTrial registeredMay 8, 2026Source filing (opens the source filing in a new tab)

Momentum

84no change

Momentum 84 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase II

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

995 pre-ticker oncology companies at Phase II

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    Study registered

    Mar 22, 2024

    Thoracic Cancer · RECRUITING · sponsor: The New York Proton Center · Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer

    ClinicalTrials.gov · NCT06342284 (opens the source filing in a new tab)

  2. Trial

    NA registered

    Aug 26, 2021

    Non-small Cell Lung Cancer, Non-small Cell Lung Cancer Stage III, Recurrent Non Small Cell Lung Cancer · TERMINATED · sponsor: NRG Oncology · Testing the Addition of Activity Monitoring With a Wearable Electronic Device to Improve Patient Care During Treatment for Lung Cancer

    ClinicalTrials.gov · NCT04878952 (opens the source filing in a new tab)

  3. Trial

    PHASE2 registered

    Jul 1, 2016

    Non-small Cell Lung Cancer (NSCLC) · COMPLETED · sponsor: Montefiore Medical Center · FLT3 Ligand Immunotherapy and Stereotactic Radiotherapy for Advanced Non-small Cell Lung Cancer

    ClinicalTrials.gov · NCT02839265 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources